Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Kate Johnson

    News

    Temozolomide for Glioblastoma Benefits Elderly

    Author:
    Kate Johnson
    Publish date: February 1, 2011

    • Read More

    News

    Device for Glioblastoma May Offer Advantage Over Chemo

    Author:
    Kate Johnson
    Publish date: January 1, 2011

    • Read More

    News

    Bevacizumab Effective in Glioblastoma Trials

    Author:
    Kate Johnson
    Publish date: January 1, 2011

    • Read More

    News

    Brief Decline in Quality of Life Seen After Brain Radiotherapy

    Author:
    Kate Johnson
    Publish date: December 15, 2010

    Major Finding: Global HRQOL scores at 9 months were significantly worse in patients who received WBRT than in those who underwent observation...

    • Read More

    News

    Frail Elderly Benefit From Post-Op Temozolomide for Glioblastoma

    Author:
    Kate Johnson
    Publish date: December 9, 2010

    Major Finding: More than half of patients with a median Karnofsky performance score of 60 improved their score by at least 10 points.Data Source:...

    • Read More

    News

    New Drugs Target Recurrent Meningioma

    Author:
    Kate Johnson
    Publish date: December 3, 2010

    Major Finding: Two phase II studies of vatalanib and sunitinib showed 6-month progression-free survival rates of 57% and 36%, respectively.Data...

    • Read More

    News

    New Drugs Target Recurrent Meningioma

    Author:
    Kate Johnson
    Publish date: December 3, 2010

    Major Finding: Two phase II studies of vatalanib and sunitinib showed 6-month progression-free survival rates of 57% and 36%, respectively.Data...

    • Read More

    News

    Study Adds Uterine Fibroids to Meningioma Risk Factors

    Author:
    Kate Johnson
    Publish date: December 3, 2010

    Major Finding: Postmenopausal women with a history of uterine fibroids had a relative risk of 1.78 for meningioma, compared with women without...

    • Read More

    News

    Device for Glioblastoma May Offer Advantage Over Chemo

    Author:
    Kate Johnson
    Publish date: December 1, 2010

    Major Finding: In a subgroup of 110 patients aged younger than 60 years who had a Karnofsky score greater than 80%, the 1-year overall survival...

    • Read More

    News

    PTSD Treatment Research Begins to Target Memory Reconsolidation

    Author:
    Kate Johnson
    Publish date: December 1, 2010

    • Read More

    News

    Watch for Vascular, Other Risks in PTSD Patients

    Author:
    Kate Johnson
    Publish date: December 1, 2010

    • Read More

    News

    Role of Combat Trauma In PTSD Is Reinforced

    Author:
    Kate Johnson
    Publish date: December 1, 2010

    Major Finding: Symptoms of posttraumatic stress disorder were seen in 50 of 104 Vietnam veterans and in none of their nonveteran identical twins...

    • Read More

    News

    Global Rate of Paternal Depression Surpasses 10%

    Author:
    Kate Johnson
    Publish date: December 1, 2010

    Major Finding: An overall 10.4% rate of paternal depression correlated with maternal depression.Data Source: A meta-analysis of 43 studies...

    • Read More

    News

    d-Cycloserine for PTSD Proves Underwhelming

    Author:
    Kate Johnson
    Publish date: December 1, 2010

    Major Finding: Remission rates were at 55% for the placebo group and 48% for the treated group immediately after the treatment. Data Source:...

    • Read More

    News

    Propranolol Shows Early Promise for PTSD

    Author:
    Kate Johnson
    Publish date: December 1, 2010

    Major Finding: Propranolol administered at traumatic memory recall appears to block reconsolidation of the memory. Data Source: A randomized,...

    • Read More

    Pages

    • « first
    • …
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery